rachel yalowich project director, national …...(opioid agonist treatment) following a non-fatal...
TRANSCRIPT
![Page 1: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/1.jpg)
Moderator
Rachel Yalowich, Project Director, National Academy for State Health Policy
![Page 2: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/2.jpg)
Logis.cs for the Webinar
• Ifyouareunabletolistentothewebinarthroughyourcomputerspeakers,pleaseuseyourphone:Dialin:(866)519-2796AccessCode:725013
• Lineswillnotbeopenduringthiswebinar.
• Commentsareencouraged.PleaseusethatchatboxonthelowerleMcornerofyourscreen.
• Thechatfeatureisavailable,butwillnotbevisibleinfullscreenmode
![Page 4: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/4.jpg)
Why is data viz so important?
Take Action Make Change
Communicate Need
Funding Illuminate Findings
Data Driven Decisions
Efficiency
![Page 5: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/5.jpg)
![Page 6: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/6.jpg)
![Page 7: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/7.jpg)
AccesstospacemustbeanaPonalpriority.
![Page 8: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/8.jpg)
VISUALIZATION PROCESS
![Page 9: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/9.jpg)
1.Buildit 2.Breakitdown 3.Emphasizeyourstory
VISUALIZATION PROCESS
![Page 10: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/10.jpg)
VISUALIZATION PROCESS
1.Buildit 2.Breakitdown 3.Emphasizeyourstory
![Page 11: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/11.jpg)
55%
45%
34%55%
45%
34%
34%
45%
55%
![Page 12: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/12.jpg)
55%
45%
34%55%
45%
34%
34%
45%
55%
CHART FUNK?
![Page 13: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/13.jpg)
CHOOSING THE RIGHT CHART
![Page 14: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/14.jpg)
100
80
75
8050
60
55
50
40
42
30 20
Jan Feb Mar April May June July Aug Sept Oct Nov Dec
Overthecourseoftheyear,salesdecreased.
![Page 15: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/15.jpg)
100
8075
80
50
6055
50
40 42
30
20
Jan Feb Mar April May June July Aug Sept Oct Nov Dec
Overthecourseoftheyear,salesdecreased.
![Page 16: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/16.jpg)
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
Maine
Wyoming
Arkansas
MassachuseZs
Alaska
Colorado
Montana
Idaho
NewYork
WestVirginia
Maryland
Delaware
Minnesota
Nevada
Texas
California
Virginia
Vermont
Louisiana
Illinois
Michigan
NorthCarolina
Georgia
NewJersey
Oregon
Florida
NewHampshire
Oklahoma
SouthDakota
Kansas
Utah
Kentucky
Missouri
Washington
![Page 17: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/17.jpg)
![Page 18: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/18.jpg)
![Page 19: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/19.jpg)
1.Buildit 2.Breakitdown 3.Emphasizeyourstory
VISUALIZATION PROCESS
![Page 20: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/20.jpg)
REDUCE CLUTTER
![Page 21: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/21.jpg)
![Page 22: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/22.jpg)
0 50 100 150 200 250
Chicken
Beef
Fish
Tofu
Pork
Beans
ProteinPreference
ExtremelyDislike
Dislike
SlightlyDislike
Neutral
SlightlyLike
Like
ExtremelyLike
![Page 23: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/23.jpg)
30
45
60
115
120
210
20
20
50
20
10
10
215
200
155
130
135
45
Chicken
Beef
Fish
Beans
Pork
Tofu
OfallproteinopPons,mostpeopledisliketofu.
Dislike Neutral Like
![Page 24: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/24.jpg)
GESTALT
![Page 25: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/25.jpg)
Proximity
![Page 26: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/26.jpg)
![Page 27: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/27.jpg)
![Page 28: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/28.jpg)
ExamplefromEvergreenData’sblog“DirectlyLabelinginExcel”
![Page 29: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/29.jpg)
ExamplefromEvergreenData’sblog“DirectlyLabelinginExcel”
![Page 30: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/30.jpg)
YES!
NO
ExamplefromStephanieEvergreenandJenniferLyonsresearchon“TheLinkBetweenGraphicDesignandActualReportUse”
![Page 31: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/31.jpg)
FocalPoint
![Page 32: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/32.jpg)
13
11
6
11 11
4
10
45
2
12
4
8
Jan. Feb. Mar. April May June July Aug. Sept. Oct. Nov. Dec.
There is an average in-flow of 8 veterans coming into our homeless system every month.
![Page 33: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/33.jpg)
13
11
6
11 11
4
10
45
2
12
4
8
Jan. Feb. Mar. April May June July Aug. Sept. Oct. Nov. Dec.
There is an average in-flow of 8 veterans coming into our homeless system every month.
![Page 34: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/34.jpg)
ConHnuity
![Page 35: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/35.jpg)
13
11
6
11 11
4
10
45
2
12
4
8
Jan. Feb. Mar. April May June July Aug. Sept. Oct. Nov. Dec.
There is an average in-flow of 8 veterans coming into our homeless system every month.
![Page 36: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/36.jpg)
13
11
6
11 11
4
10
45
2
12
4
8
Jan. Feb. Mar. April May June July Aug. Sept. Oct. Nov. Dec.
There is an average in-flow of 8 veterans coming into our homeless system every month.
![Page 37: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/37.jpg)
1.Buildit 2.Breakitdown 3.Emphasizeyourstory
VISUALIZATION PROCESS
![Page 38: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/38.jpg)
STRATEGIC TEXT
![Page 39: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/39.jpg)
ExamplefromAnnEmery’sBlog
![Page 40: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/40.jpg)
ExamplefromAnnEmery’sBlog
![Page 41: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/41.jpg)
DescripHveTitle AcHveTitle
![Page 42: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/42.jpg)
DescripHveTitle AcHveTitle
Protein Preferences
![Page 43: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/43.jpg)
DescripHveTitle AcHveTitle
Protein Preferences Of all protein options, most people dislike tofu.
![Page 44: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/44.jpg)
DescripHveTitle AcHveTitle
Protein Preferences Of all protein options, most people dislike tofu.
2015 vs. 2016 Program Enrollment by Race
Protein Preferences Of all protein options, most people dislike tofu.
![Page 45: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/45.jpg)
DescripHveTitle AcHveTitle
Protein Preferences Of all protein options, most people dislike tofu.
2015 vs. 2016 Program Enrollment by Race
2016 enrollment for people of color has increased by 5%.
![Page 46: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/46.jpg)
DescripHveTitle AcHveTitle
Protein Preferences Of all protein options, most people dislike tofu.
2015 vs. 2016 Program Enrollment by Race
2016 enrollment for people of color has increased by 5%.
Customer Satisfaction Survey Results
![Page 47: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/47.jpg)
DescripHveTitle AcHveTitle
Protein Preferences Of all protein options, most people dislike tofu.
2015 vs. 2016 Program Enrollment by Race
2016 enrollment for people of color has increased by 5%.
Customer Satisfaction Survey Results
Overall, respondents were most satisfied by our organization’s customer service and follow-up.
![Page 48: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/48.jpg)
COLOR
![Page 49: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/49.jpg)
![Page 50: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/50.jpg)
I love learning about data visualization. It is so great to learn all of these new data best practices I will apply the things I have learned today to the data I use in my own work. Data visualization helps me better tell my story and communicate with my intended audience.
![Page 51: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/51.jpg)
I love learning about data visualization. It is so great to learn all of these new data best practices I will apply the things I have learned today to the data I use in my own work. Data visualization helps me better tell my story and communicate with my intended audience.
![Page 52: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/52.jpg)
2outof10peoplereceivingourservicesarewomen.
2outof10peoplereceivingourservicesarewomen.
VS.
![Page 53: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/53.jpg)
20%
30%
40%
50%
60%
70%
80%
Jan Feb Mar April May June July Aug Sept Oct Nov Dec
Region1 Region2 Region3 Region4 Region5
Regionalsalesfor2015
![Page 54: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/54.jpg)
Jan Feb Mar April May June July Aug Sept Oct Nov Dec
Regionthreesustainedtheusualsummersalesslump.
80%
20%
70%
60%
50%
40%
30%
Region3
Region4
Region2
Region1
Region5
![Page 55: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/55.jpg)
Jan Feb Mar April May June July Aug Sept Oct Nov Dec
Allsalesincreasedsignificantlyduringtheholidayseason.
80%
20%
70%
60%
50%
40%
30%
Region3
Region4
Region2
Region1
Region5
![Page 56: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/56.jpg)
COLOR
ExamplefromEvergreenData’sBlog
![Page 57: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/57.jpg)
![Page 58: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/58.jpg)
SOCIAL MEDIA
![Page 59: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/59.jpg)
PRESS
![Page 60: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/60.jpg)
![Page 61: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/61.jpg)
![Page 62: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/62.jpg)
![Page 63: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/63.jpg)
![Page 64: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/64.jpg)
![Page 65: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/65.jpg)
DASHBOARD
ExamplefromNatalyaWawrin’sworkwiththeVAinAnnArbor
![Page 66: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/66.jpg)
![Page 68: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/68.jpg)
MA DEPARTMENT OF PUBLIC HEALTH Monica Bharel, MD MPH Commissioner of Public Health
![Page 69: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/69.jpg)
HIV/AIDS IN MASSACHUSETTS
July 2017
![Page 70: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/70.jpg)
People Diagnosed with HIV Infection by Exposure Mode 2013 - 2015
by Exposure Mode: Massachusetts, 2013–2015
N=1,994 Undetermined
28%
Heterosexual Sex6%
Injection Drug Use6%
MSM/IDU2%
Other1%
Presumed Heterosexual Sex (Females)
13%
Male-to-Male Sex44%
Data Source: MDPH HIV/AIDS Surveillance Program, Data as of 1/1/17
![Page 71: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/71.jpg)
Individuals Diagnosed with HIV Infection by Exposure Mode and Year of Diagnosis: Massachusetts, 2005–2015
0
50
100
150
200
250
300
350
400
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015Year of Diagnosis
HIV
Dia
gnos
es
IDU Pres. HTSX HTSX
Data Source: MDPH HIV/AIDS Surveillance Program; Data as of 1/1/17
MSM
MSM/IDU
NIR
Other
![Page 72: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/72.jpg)
Percentage Distribution of Deaths among People Reported with HIV/AIDS: Selected Exposure Modes & Year of Death: 2005–2014
0%
10%
20%
30%
40%
50%
60%
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Percent
Year of Diagnosis
N=2,732; HTSX = Heterosexual Sex; Pres. HTSX = Presumed Heterosexual Sex Data Source: MDPH HIV/AIDS Surveillance Program; Data are current as of 3/1/16 and may be subject to change
PRES. HTSX
Undetermined
Injection Drug Use
Male-to-Male Sex
HTSX
![Page 73: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/73.jpg)
Proportion of Individuals Diagnosed with HIV Infection Among PWID by Race and Year of Diagnosis:
Massachusetts, 2012–2015
Data Source: MDPH HIV/AIDS Surveillance Program; Data as of 1/1/17
![Page 74: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/74.jpg)
OPIOIDS: USING DATA TO UNCOVER TRUTHS AND GUIDE POLICY July 2017
![Page 75: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/75.jpg)
Opioid Related Deaths
379506 526
614514 575
660 642 622 638 560656
742
961
1,361
1,6511,933
1,793
2,069
0200400600800
1,0001,2001,4001,6001,8002,0002,200
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Num
berofd
eaths
Figure1.Opioid1-RelatedDeaths,AllIntentsMassachusettsResidents:January2000- December2016
Confirmed Estimated
70% OF OPIOID DEATHS IN 2016 HAD THE PRESENCE OF FENTANYL
446% INCREASE IN 16 YEARS
![Page 76: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/76.jpg)
Opioid Related Deaths
0
10
20
30
40
50
60
70
80
90
1 2 3 4 1 2 3 4 1 2 3 4
2014 2015 2016
Percen
t
YearandQuarter
Figure4.PercentofOpioidDeathswithSpecificDrugsPresentMA:2014-2016
Fentanyl¹
LikelyHeroin
PrescriptionOpioid²
Benzodiazepine
Cocaine
![Page 77: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/77.jpg)
Opioid Related Deaths
![Page 78: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/78.jpg)
Opioid Overdose Death Rates, All Intents Massachusetts: 2011-2013 vs. 2014 - 2016
![Page 79: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/79.jpg)
Prevention Intervention Treatment Recovery
Governor Baker’s Opioid Working Group
![Page 80: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/80.jpg)
Massachusetts Chapter 55 Legislation • Signed into law in August 2015
• Requires a comprehensive report to the state legislature and cross-agency collaboration to address 7 specific questions about opioid-related deaths
• Specifies major data sets across government
• Overcomes legal barriers for use of some data
• Work highlighted by Public Health Accreditation Board on their site visit
![Page 81: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/81.jpg)
Chapter 55 Data Mapping
PDMP
APCDSpine
DeathRecords
BSASTreatment
Toxicology
MedicalClaims
MATRIS(EMS)
OCMEIntake
HospitalandED
MAPrisons
MAJails
MassHealth
DMH DHCD
StatePoliceOpioid
BirthRecords
Veterans’Services
TransiHonalAssistance
YouthServices
Children&Families
ServiceIndicatorFlagsCancerRegistry
DeptDevServices
CommissionforBlind
Chapter55DataStructure
NeedleExchange
NARCANDistribuHon
DrugSeizureData
Town&ZipCensusData
CommunityLevelData
MDPHnetDepression
I.C.E.Measures
![Page 82: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/82.jpg)
PSI#1
PSI#1APCDSPINEPSI#1
PSI#1
PSI#1
PSI#1
PSI#1&#N
PSI = Project Specific Identifier
Enterprise SAS or other software (Fixed or Cloud-based servers)
Machine 1
Machine 2
Machine 5 Machine
4 Machine
3
Machine 6
Machine 7
Machine N
Machine 8
…addiHonaldata…
…addiHonalmachines…
…addiHonaldata…
Chapter 55 Privacy Shield: Authorized users only, no write access, analysts cannot see data, automatic cell suppression, delete all temporary work files, full auditability of all data operations.
DRAFT - FOR POLICY DEVELOPMENT ONLY
PSI#2&AnalyPc
PSI#3&AnalyPc
PSI#4&AnalyPc
PSI#5&AnalyPc
PSI#N&AnalyPc
Chapter55:SecureDataAccess
![Page 83: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/83.jpg)
Chapter55:PartnersComingTogetherAcademic
• BrandeisUniversity• BostonUniversity• BrownUniversity• HarvardMedicalSchool• HarvardSchoolofPublicHealth• MassachuseasCollegeofPharmacyandHealthSciences• MassachuseasInsHtuteofTechnology• NortheasternUniversity• TubsUniversity• UniversityofMassachuseasAmherst• UniversityofMassachuseasBoston• UniversityofMassachuseasMedicalSchool
StateandFederalGovernmentAgencies
Hospitals&PrivateIndustry
• BaystateHealth• BethIsraelDeaconessMedicalCenter• BostonMedicalCenter• Brigham&Women’sHospital• Children’sHospital• GE• IBM• LibertyMutual• MassachuseasGeneralHospital• MassachuseasLeagueofCommunityHealthCenters• McKinsey&Company• TheMITRECorporaHon• PartnersHealthcare• PwC• RandCorporaHon
• BostonPublicHealthCommission• CenterforHealthInformaHonandAnalysis• DepartmentofHousingandCommunityDevelopment• DepartmentofMentalHealth• DepartmentofCorrecHon• DepartmentofPublicHealth• ExecuHveOfficeofHealthandHumanServices• ExecuHveOfficeofPublicSafetyandSecurity
• FederalBureauofInvesHgaHon• HighIntensityDrugTraffickingArea(NE)• HealthPolicyCommission• MassachuseasSheriffs’AssociaHon• MassIT• OfficeoftheChiefMedicalExaminer• StateAuditor’sOffice
![Page 84: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/84.jpg)
Data Mapping: Key finding
• Patients treated with methadone and/or buprenorphine (Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die.
• Very few patients (~5%) receive Opioid Agonist Treatment following a non-fatal overdose.
0
0.5
1
1.5
2
2.5
Engaged in OAT Not Engaged in OAT
Cum
ulat
ive
Inci
denc
e (%
)
Cumulative Incidence of Opioid-Related Death by Opioid Agonist Treatment Status
![Page 85: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/85.jpg)
Data Mapping: Key finding The risk of opioid overdose death following incarceration is 56 times higher than for the general public.
869.4 opioid deaths / 100,000
15.4 opioid deaths/ 100,000
0
100
200
300
400
500
600
700
800
900
1000
Former Inmates All Others
Comparison of Opioid Death Rates Among Former Inmates to the Rest of State (2013 - 2014)
![Page 86: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/86.jpg)
Does an abnormally high amount of
prescribing physicians increase a
patient’s risk of fatal overdose?
Individuals who obtain opioid prescriptions from
more than 1 doctor may be at greater risk of death.
Based on observed data, the use of 3 or more prescribers
is associated with a 7-fold increase in risk of fatal
opioid overdose.
Does the addition of benzodiazepines to opioids increase
the risk of fatal opioid overdose
relative to taking opioids alone?
Preliminary findings support the hypothesis of increased risk of fatal overdose associated with concurrent use of opioids and
benzodiazepines.
Based on observed data, the use of benzodiazepines concurrent to opioids is associated with a 4-fold
increase in risk of fatal opioid overdose.
ANALYTIC QUESTION PRELIMINARY FINDING
Datamapping–KeyFindings
![Page 87: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/87.jpg)
PMP activity trends
![Page 88: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/88.jpg)
14.3 13.6
10.6
7.7
4.0
8.0
12.0
16.0
2013 2014 2015 2016
Rateper1,000In
dividu
als
Figure3.Rate1 ofIndividualswithActivityofConcern2 inMA3
2013–2016
ActivityofConcern
1 Ratesofindividualswithactivityofconcernarebasedonthepopulationofindividuals whohavereceivedoneormoreSchedule IIopioidprescriptions.2 "ActivityofConcern"isdefinedasanindividual whoreceivedprescriptions foroneormoreScheduleIIopioiddrugsfromfourormoredifferentprescribersandhadthemfilledatfourormorepharmaciesduring thespecifiedtimeperiod.3 ActivityofconcernratesincludeonlyMAResidents
PMP activity trends
![Page 89: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/89.jpg)
6.0
7.9
8.2
9.6
8.08.9
10.3 10.0
9.6
9.7
8.010.0
11.2 14.4
20.2
26.4
30.5
0
5
10
15
20
25
30
35
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Rate
per1
00,000
Residen
ts
Figure3.RateofOpioid1-RelatedDeaths,AllIntentsMassachusettsResidents:2000-2016
Opioid Related Deaths
40%
31%
16%
![Page 90: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/90.jpg)
Data visualization of findings from Chapter 55 Report
Monica Bharel, MD, MPH Commissioner, Massachusetts Department of Public Health
http://www.mass.gov/chapter55/
![Page 91: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/91.jpg)
Opioid map – Chapter 55 Visualization
Chapter 55 website allows for town-by-town analysis
![Page 92: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/92.jpg)
Chapter 55 Visualization
Adding interactive elements to help localize the epidemic
![Page 93: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/93.jpg)
Connecting data with a story…
![Page 94: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/94.jpg)
THANK YOU & QUESTIONS
![Page 95: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/95.jpg)
Ques.ons
![Page 96: Rachel Yalowich Project Director, National …...(Opioid Agonist Treatment) following a non-fatal overdose were significantly less likely to die. • Very few patients (~5%) receive](https://reader033.vdocument.in/reader033/viewer/2022053008/5f0bc0c87e708231d4320c01/html5/thumbnails/96.jpg)
HIVHealthImprovementAffinityGroup
ThankyouforparPcipaPngintoday’swebinar!PleasecompletetheevaluaPonaMerexiPngthewebinar.